valproic acid and abt-510

valproic acid has been researched along with abt-510 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chlenski, A; Cohn, SL; Henkin, J; Liu, S; Salwen, HR; Tian, Y; Yang, Q; Zeine, R	1

Other Studies

1 other study(ies) available for valproic acid and abt-510

Article	Year
Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma. Cancer research, 2007, Feb-15, Volume: 67, Issue:4 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Capillary Permeability; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Down-Regulation; Endothelial Cells; Female; Fibroblast Growth Factor 2; Humans; Mice; Neovascularization, Pathologic; Neuroblastoma; Oligopeptides; Valproic Acid; Xenograft Model Antitumor Assays	2007

Article

Year

Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.

Cancer research, 2007, Feb-15, Volume: 67, Issue:4

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Capillary Permeability; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Cell Movement; Down-Regulation; Endothelial Cells; Female; Fibroblast Growth Factor 2; Humans; Mice; Neovascularization, Pathologic; Neuroblastoma; Oligopeptides; Valproic Acid; Xenograft Model Antitumor Assays

2007